Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.

about

A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

P2860

Q28553344-7184D2A3-EE19-41BE-B122-E815E811F2E3 Q38959281-17A745C8-2E2D-4460-A473-B0078A8E084F

P2860

Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.

Item

http://www.wikidata.org/entity/Q36232528

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@ast

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@en

type

Item

label

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@ast

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@en

prefLabel

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@ast

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@en

P1476

Comparison of Deconvolution-Ba ...... II Drug Development Candidate.

@en

P2093

Binfeng Xia

http://www.w3.org/2001/XMLSchema#string

Filippos Kesisoglou

http://www.w3.org/2001/XMLSchema#string

Nancy G B Agrawal

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro - in vivo correlation: from theory to applications

Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

Population-based mechanistic prediction of oral drug absorption

PBPK models for the prediction of in vivo performance of oral dosage forms.

In vitro/in vivo correlations: scientific implications and standardisation.

In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers.

Suitability of a minipig model in assessing clinical bioperformance of matrix and multiparticulate extended-release formulations for a BCS class III Drug development candidate.

Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailability.

Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption.

P2888

s12248-015-9816-7

P304

1492-1500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-015-9816-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045698909

http://www.w3.org/2001/XMLSchema#string

P698

26290380

http://www.w3.org/2001/XMLSchema#string

P921

deconvolution

P932

4627461

http://www.w3.org/2001/XMLSchema#string

Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.

about

P2860

P2860

Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P932